The FDA approved fam-trastuzumab derextecan-nki (Enhertu; Daiichi Sankyo, Inc), a HER2-directed antibody-drug conjugate (ADC), in combination with pertuzumab as a first-line treatment for patients ...

The Carolina Panthers are still learning how to handle success. While the Panthers have thrived in the underdog role this ...

Bandai Namco celebrated the 30th anniversary of the Tales of series with two videos highlighting characters and games in the ...

Marathon is looking pretty promising after getting visual overhauls and a release date. Will it be enough to save the game?

Enhertu plus Perjeta is the first new first-line treatment for HER2-positive breast cancer in over a decade, approved by the ...

Issues delivered straight to your door or device We're so back... maybe?

The FDA's approval is based on results from the Phase III DESTINY-Breast09 trial, in which the combo showed a median 40.7-month progression-free survival.

In a nearly 23-minute video detailing Bungie's changes to Marathon in recent months, the developer confirms the features that ...

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

The FDA approved T-DXd plus pertuzumab for HER2-positive metastatic breast cancer, based on DESTINY-Breast09 trial results. The combination therapy reduced disease progression or death risk by 44% ...

Destiny 2's Tier 5 loot is hugely power crept, and now anything below that feels bad to get, especially in new endgame ...

Families lined up along King Street on Saturday night for the annual Leesburg Holiday Parade. For more than an hour, entries ...